Catapult Ventures

Catapult Ventures, founded in 1999 and based in Leicester, is an independent asset management firm specializing in early-stage investments in technology, life sciences, and healthcare companies across the United Kingdom. With a team of highly experienced venture capital investors, Catapult Ventures has a proven track record in various sectors including healthcare, pharmaceuticals, luxury consumer brands, manufacturing, and software. The administration team, each member boasting over a decade of experience in the venture capital environment, ensures efficient and knowledgeable support for all stages of investment from start-ups to company floatation.

Duncan Cameron

CFO

Rob Carroll

Director

Vijay Curthan

Investment Director

Tony Flinn

Venture Partner GM&C Life Sciences Fund

Emma Johnson

Associate of GM&C Life Sciences Fund

Gareth King

Life Science Partner

Ed Wass

Chief Investment Officer

Dr. David Whitcombe

Venture Partner GM&C Life Sciences Fund

Nick Wright

CEO

125 past transactions

Zinwave

Funding Round in 2010
Zinwave was not born from business opportunity, but rather, a curiosity. Some of the best academic minds in the world couldn’t accept that there wasn’t a better way to provide wireless connectivity and transmit radio frequencies indoors. Their research led, ultimately, to the patented technologies that became the Zinwave distributed antenna system. Since launching our first commercial product in 2008, we have installed distributed antenna systems all over the world for customers in nearly every industry: commercial real estate, healthcare, hospitality, enterprise, public venues, wholesale data centers, education and emergency services. It’s those customers that are our focus. We have a passion for not just meeting needs but exceeding them and doing it with innovative solutions.

Sight and Sound Limited

Acquisition in 2008
Sight and Sound is a UK-based provider of hardware and software to the blind, visually impaired and those with learning and reading difficulties.

Viscgo

Venture Round in 2021
Viscgo Limited designs, develops, and delivers devices and technology to improve the management of dysphagia for patients, caretakers, and clinicians. The company’s product includes drink thickness testers. The company was founded in 2015 and is based in Warrington, United Kingdom.

Biorelate

Seed Round in 2016
Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.

Key Technologies

Seed Round in 2008
Key Technologies Ltd., through its subsidiaries, provides engineering solutions in the areas of Defense and Homeland Security. The company manufactures and supplies specialist ammunition, 12 gauge, EOD, and public order solutions through a distribution network worldwide. It also engages in design, electronic manufacturing, and through-life system engineering services. Key Technologies Ltd. was founded in 2003 and is based in Cradley Heath, United Kingdom.

Renephra

Private Placement in 2018
Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide. Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.

Acea Health Limited

Private Placement in 2018
Acea Health Limited develops a digital dental and medical consent platform called Flynotes. The company caters to patients and clinicians. The company was incorporated in 2016 and is based in Guildford, United Kingdom.

Camect

Pre Seed Round in 2020
Camect is a very smart and private hub for your security cameras. Camect brings _continous_ local recording and 100% local object detection AI to your security cameras, plus a good UI and easy remote access. Manage hundreds of camera brands (including Nest, Arlo, and Wyze!) from one app, and get better alerts than any other consumer product, for orders of magnitude less than what a comparable feature set costs using common big brand consumer products.

Oxford BioTherapeutics

Venture Round in 2008
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Intelligent Orthopaedics

Venture Round in 2011
Intelligent Orthopaedics designs, develops, and manufactures orthopedic trauma devices for treating and reducing fractures of the tibia. It offers STORM (The Staffordshire Orthopaedic Reduction Machine), a re-usable surgical device for the reduction of fractures throughout the tibia. The company also provides IOS, a single use fixator to treat unstable tibial shaft fractures. Intelligent Orthopaedics was incorporated in 2002 and is based in Newcastle-under-Lyme, United Kingdom. As of September 05, 2016, Intelligent Orthopaedics is in liquidation.

Warwick Effect Polymers

Venture Round in 2009
Warwick Effect Polymers Limited manufactures and markets complex polymers using living controlled radical polymerization.

Oxford Cryosystems

Acquisition in 2010
Oxford Cryosystems is privately held with 20 employees, and is a market-leading UK manufacturer of highly specialised scientific instruments and software. The company originated in a laboratory of Oxford University in the 1980s and has since grown into a high-tech commercial organisation. To date, Oxford Cryosystems products have contributed to advances in fields as diverse as pharmaceuticals, telecoms, green energy and astronomy. Customers include universities, high-tech manufacturers, drugs companies and research institutes throughout the world. More than 80% of production is currently exported, whilst at least 90% of the company’s suppliers are British-based. For more information, visit www.oxcryo.com.

nanoTherics

Venture Round in 2010
nanoTherics gene transfection studies have shown a significant performance enhancement over the best non-viral techniques currently on the market, demonstrating high levels of transfection whilst, importantly, maintaining the viability of the transfected cells. These two key attributes afford a significant competitive advantage over currently available systems. nanoTherics’s mission is to position its novel gene transfection technology as the new “gold standard” for transfection, underpinning the research and development of current and future gene therapy programmes.

Left Hand Robotics

Series A in 2019
Left Hand Robotics has developed the first commercial-class, self-driving snow clearing robot capable of removing snow from sidewalks and walkways. The SnowBot Pro is controlled and monitored remotely from an online management dashboard and uses GPS to follow a pre-programmed path. Its rotating brush clears a sidewalk from edge-to-edge in a single pass to meet even the highest standards.

Turbine Efficiency

Venture Round in 2003
Turbine Efficiency is a provider of after-market services for industrial gas turbines, specialising in sub-10MW machines. It also offers light industrial gas turbine equipment solutions for the oil, gas, and power & industrial markets. Turbine Efficiency specialising in the SGT-100 (Typhoon), SGT-200 (Tornado), SGT-300 (Tempest), TA and TB gas turbines. Turbine Efficiency has received the Lincolnshire Energy Awards - Exporter of the Year 2014. It was founded in 2000 and is headquartered in Lincoln, UK.

4energy Ltd.

Venture Round in 2008
4energy Ltd. develops energy cooling systems and platforms for telecommunications and equipment rooms.

AMR Centre

Private Placement in 2019
Anti-Microbial Research Centre aims to accelerate the development of new antibiotics by providing development services to companies around the world in return for a commercial share from new products developed.

Intellitect Water Holdings

Venture Round in 2010
Intellitect has developed a water quality monitoring system that allows your distribution network to talk to you. It gives you all the information you need to ensure a high-quality product reaches the customer. Water companies produce high-quality water at the treatment plants under well-controlled conditions, however, once the water is pumped into the distribution network they lose the ability to monitor its quality. Our Insight system alerts you if there is a problem and tells you where and when, straight to your computer or mobile device, allowing you to act quickly.

Biohabit Ltd

Private Placement in 2020
Biohabit Ltd develops a salivary test for diagnosis of heart failure. The company was incorporated in 2019 and is based in Liverpool, United Kingdom.

Kanichi Research Services

Venture Round in 2016
Kanichi Research Services are developing novel non-invasive diagnostic systems that measure analytes in exhaled breath for the rapid detection and diagnosis of a range of diseases. The lead product is a low-cost, disposable, point of care test for the detection and diagnosis of Helicobacter Pylori (H. pylori), a bacterial infection in the gut which can lead to stomach ulcers and stomach cancer.

Maxwellia

Venture Round in 2021
Maxwellia is a pioneering ‘prescription to over the counter’ medicines company which specialises in ‘switching’ - the conversion of prescription medicines into branded versions that can be bought without a prescription, over the counter (OTC).

Cyclops

Venture Round in 2004
Cyclops offers safety camera databases, update services, and related software. Cyclops' coverage now extends across 41 countries and includes over 85,000 sites. Users of Cyclops devices, software and databases know they can rely on Cyclops' solutions to help them arrive safely at their destination, and with their driving record intact. Cyclops delivers tailored solutions for clients operating on all types of software and hardware platforms including personal navigation, connected mobile devices, and OEM satnav solutions. Today, Cyclops' databases and software can be found in leading satellite navigation, mobile, and automotive brands, Cyclops now provides a Live Alert Service for connected PND and mobile navigation users.

MicroBioSensor

Venture Round in 2017
Microbiosensor Ltd., a medical device company, develops and delivers disposable point-of-care safety monitors for detecting microbial infection and antibiotic resistance in patients with chronic wounds. It offers disposable devices for peritoneal dialysis; devices for use with existing urinary catheter systems; and point-of-care monitoring devices to provide a rapid method of monitoring bacterial infection at a wound site. Microbiosensor Ltd. was formerly known as Microsensor Ltd. and changed its name to Microbiosensor Ltd. in July 2015. The company was founded in 2012 and is based in Manchester, United Kingdom.

Abzena

Venture Round in 2008
Abzena (AIM: ABZA) provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products, a growing area that requires specialist knowledge and expertise. The Group has a global customer base which includes the majority of the top 20 biopharmaceutical companies as well as large and small biotech companies and academic groups. The term “Abzena inside” is used by Abzena to describe products that have been created using its proprietary technologies and are being developed by its partners, and include Composite Human Antibodies™ and ThioBridge™ Antibody Drug Conjugates (ADCs). Abzena has the potential to earn future licence fees, milestone payments and/or royalties on “Abzena inside” products. Abzena offers the following services and technologies across its sites in Cambridge (UK), San Diego, California (USA) and Bristol, Pennsylvania (USA). •Immunogenicity assessment, protein engineering to create humanized antibodies and deimmunised therapeutic proteins, and cell line development for manufacture. •Contract process development and manufacture of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, vaccines, and gene therapy and cell therapy products, for preclinical and clinical studies. •Proprietary site-specific conjugation technologies for antibody drug conjugate development and solutions for optimizing the therapeutic properties of biopharmaceuticals. •Contract chemistry and bioconjugation business focused on ADCs and is establishing the capability to manufacture ADCs to GMP standards

Comply Serve

Venture Round in 2012
Comply Serve is a software company offering compliance and validation solutions to highly regulated industries. The company evolved out of the world's leading provider of requirements management solutions, Telelogic AB, where the founding team discovered a significant and largely untapped market opportunity for project supply chain compliance solutions. After 3 years spent researching the compliance market, it started trading in January 2006.

Synchro

Venture Round in 2007
Synchro, Ltd. provides project management solutions. It provides Synchro 4D, a project management and 4D visualisation solution that incorporates the ability to define and represent the physical properties of resources, and communicate these in 3D and 4D. The company also provides Synchro Server that acts as a bridge between project participants and enables to broadcast the changes made on one client to all other connected participants. Its products are used in various construction and refurbishment projects in commercial, civil, and residential segments. The company was founded in 2001 and is based in Coventry, the United Kingdom.

Monica Healthcare

Seed Round in 2005
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Silver Lining Solutions

Venture Round in 2008
Silver Lining Solutions enables organisations to pinpoint and replicate the employee skills, knowledge and attributes that drive the best business outcomes - quickly, cost-effectively and at scale. Companies around the world use our unique software solutions to transform the customer experience and achieve step change improvements in sales performance and operational efficiencies. Our teams have deep industry knowledge and extensive exposure to customer management, contact centre and back office environments. This first-hand exposure helps us see things from your point of view - we understand the challenges you face and know how to overcome them to unlock significant business benefits.

Proveca

Venture Round in 2017
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

OVO Biomanufacturing

Private Placement in 2020
OVO Biomanufacturing Ltd designs and develops a cloud-based defective interfering particles management technology platform for viral vaccine and gene therapy manufacturers. The company’s platform can be used to manage defective interfering particles for established and developing live attenuated and inactivated viral vaccines. The company was incorporated in 2019 and is based in Kenilworth, United Kingdom.

activ8 Intelligence

Venture Round in 2013
Activ8 Intelligence Limited provides HR software. The company offers HR reporting and analytics solutions; predictive workforce planning tools that enable organizations to make resourcing, recruitment, and talent management decisions; and predictive screening and selection solutions. It also provides metrics and measurement design, data analysis and interpretation, and human capital consultancy services. activ8 Intelligence was formerly known as active8 Human Resources Limited and changed its name in March 2007. The company was incorporated in 2005 and is based in Farnsfield, the United Kingdom.

Biofortuna

Venture Round in 2010
Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories, research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom.

Intamac Systems

Venture Round in 2009
Intamac Systems Ltd. operates a cloud based platform enabling connectivity to the Internet of Things (IoT). It helps original equipment manufacturers (OEMs) and product vendors to evolve their business models, service offerings and customer engagement for the connected home with IoT platform. It also offer a full access licence programme where companies can have complete control of the IoT software to own, operate, and develop custom solutions in a low risk way. The company was founded in 2000 and is based in Northampton, United Kingdom with additional offices in Cambridge, United Kingdom; and Trivandrum, India.

Silver Lining Solutions

Venture Round in 2010
Silver Lining Solutions enables organisations to pinpoint and replicate the employee skills, knowledge and attributes that drive the best business outcomes - quickly, cost-effectively and at scale. Companies around the world use our unique software solutions to transform the customer experience and achieve step change improvements in sales performance and operational efficiencies. Our teams have deep industry knowledge and extensive exposure to customer management, contact centre and back office environments. This first-hand exposure helps us see things from your point of view - we understand the challenges you face and know how to overcome them to unlock significant business benefits.

Yospace Technologies

Venture Round in 2010
Yospace is a mobile applications innovator and platform provider allowing digital publishers, mobile applications developers, and mobile operators to rapidly and affordably deliver mobile video services. The technology enables intelligent streaming thus promoting ad insertion and ad replacement enabling the content owner to monetise their content effectively. It specializes in workflow and delivery for multi-screen non-linear, linear, and live streaming. The company offers yospaceCDS, a mobile and Web-based video delivers platform that provides a basis for publishers, broadcasters, video ad networks, and applications developers to enable live and on-demand video services with in-stream ad insertion. It also offers a range of broadcast head-end solutions to enable the stream conditioning and ad avail detection required for dynamic ad insertion in live streaming, including automation system integration, placement opportunity information service, scheduling integration, and blackout management. The company was founded in 1999 and is based in Staines-upon-Thames, United Kingdom. Yospace Technologies Ltd. is a former subsidiary of Bauer Consumer Media Ltd.

Strella Biotechnology

Seed Round in 2020
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.

4energy

Corporate Round in 2013
Located in Nottingham, 4energy produces cooling solutions that deliver up to 50% energy savings over traditional cooling products across the data centre and telecoms industries.

Blueberry Therapeutics

Venture Round in 2016
Blueberry Therapeutics Ltd. engages in the development of therapies to treat diseases where infection and inflammation are major factors. The company offers therapies for the treatment of dermatological disorders. It uses nano polymer drug delivery technology to exploit small molecule and biologic approaches to developing treatments; and develops therapies for inflammatory bowel disease, atopic dermatitis, acne, and wound healing. The company was founded in 2011 and is based in Alderley Edge, United Kingdom.

Michelson Diagnostics

Venture Round in 2012
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

Atlantic Link Limited

Venture Round in 2008
Atlantic Link Limited develops rapid e-learning training products which enable users to design and deliver professional on-line training to thousands of employees which would, in the past, have taken months to create at great cost. It offers Content Point, a remote authoring system that enables the development of e-learning courses; Capture Point, a capture tool for the automatic creation of online software training courses; and Knowledge point, a collaboration server and learning management system that provides course launch and tracking, results storage, student import, and user and author grouping functions. The company also specializes in project management, instructional design, branding and design, technical, and account management areas, as well as provides eLearning support and hosted solutions. It serves corporate clients, as well as government and higher education markets through a network of resellers globally. Atlantic Link Limited was founded in 2002 and is based in Nottingham, United Kingdom with an additional office in Atlanta, Georgia.

Haemostatix

Venture Round in 2008
Haemostatix Ltd. develops a peptide-based platform technology to develop a pipeline of products to treat surgical bleeding with further applications in tissue repair and regenerative medicine. Its pipeline includes PeproStat, a coagulant/haemostat that is applied directly to a wound during surgery to control bleeding. The company was founded in 2003 and is based in Nottingham, United Kingdom. As of May 24, 2016, Haemostatix Ltd. operates as a subsidiary of Ergomed plc.
Advanced Farm Technologies is a robotics company for the next frontier of farming. It offers strawberry harvesting services in the Oxnard, Santa Maria. and Watsonville areas. Its robots gently handle berries to avoid bruising and fruit damage. Advanced Farm Technologies was founded in Davis, California in 2017.

Comply Serve

Venture Round in 2009
Comply Serve is a software company offering compliance and validation solutions to highly regulated industries. The company evolved out of the world's leading provider of requirements management solutions, Telelogic AB, where the founding team discovered a significant and largely untapped market opportunity for project supply chain compliance solutions. After 3 years spent researching the compliance market, it started trading in January 2006.

Elroy Air

Private Placement in 2019
Elroy Air, Inc., an aerospace and logistics company, operates a fleet of autonomous aircraft systems to deliver goods. It operates an aerial cargo delivery system to deliver heavy cargo over long distances. The company serves commercial, humanitarian aid, and military applications. The company was founded in 2016 and is based in San Francisco, California.

Maxwellia

Private Placement in 2018
Maxwellia is a pioneering ‘prescription to over the counter’ medicines company which specialises in ‘switching’ - the conversion of prescription medicines into branded versions that can be bought without a prescription, over the counter (OTC).

Cytox

Private Placement in 2019
Cytox have developed a simple genetic based blood test for the assessment of risk and diagnosis of Alzheimer's Disease in the very early stages. Alzheimer's Disease affects over 26 million people world-wide and is a growing condition as people live longer. There is currently no cure for Alzheimer's Disease, but there are large international initiatives underway to find treatments with many drugs in clinical development. Cytox are commercially launching their tests in conjunction with Affymetrix (part of Thermo Fisher Scientific) to support Pharmaceutical and Biotechnology companies developing novel therapeutics.

Blackstar Amplification

Private Equity Round in 2007
Blackstar Amplification Limited, a UK-based designer and manufacturer of innovative guitar amplifiers and effects pedals. Blackstar Amplification is based in Northampton, England. The company's four founding directors are all musicians and have over 50 years combined experience in guitar amplification design and production.

Renephra

Seed Round in 2018
Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide. Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.

Oxford BioTherapeutics

Venture Round in 2009
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

MyHelp Ltd

Private Placement in 2020
MyHelp Ltd develops, owns, and operates a platform for mental health service providers and patients. The company’s platform serves clinicians and patients. The company was incorporated in 2020 and is based in Altrincham, United Kingdom.

Zysis Limited

Venture Round in 2007
Zysis Limited is a pharmaceutical company that optimizes therapies for disorders of the central nervous system to improve sufferers’ lives. Zysis is currently developing two new treatments. One is a once-weekly, oral tablet for the treatment of Psychotic conditions or an adjunctive treatment for Major Depressive Disorder (Aripiprazole Oral Once Weekly). The other is a once-daily, effective formulation for the treatment of speciality Anxiety disorders such as Panic Disorders and Post-Traumatic Stress Disorder (Nocturel).

Oxford BioTherapeutics

Venture Round in 2007
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

Hangar Seven

Venture Round in 2011
Hangar Seven is a creative production business that works with both clients and agencies to provide an end-to-end solution for superb, yet cost effective marketing services delivery from our 50,000 sq ft facilities in London, South Manchester & Portugal. From one single point of contact we create, manage and distribute marketing and advertising assets to over 87 countries worldwide. Striking and creative photography can be produced in any one of our large studios, beautiful flyers and catalogues are crafted and put together by our publications team and above the line advertising is produced, reversioned and disseminated perfectly to press, outdoor, online and TV channels all around the globe.

SurgaColl

Private Placement in 2018
SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien, the company aims to become a leader in the field of regenerative medical devices.

Cyclops Electronics

Venture Round in 2004
Cyclops Electronics Ltd. distributes electronic components to original equipment manufacturers worldwide.

CroBio

Seed Round in 2024
CroBio is a start-up founded by individuals specialising in microbiology and engineering. The company has a vision to create an environmentally sustainable solution to managing global agricultural drought. The companies current technology is based on a genetically engineered root-associated bacteria that has self-sustaining biologically active water retention. The bacteria naturally occur around the roots of many crops such as corn, wheat and soybean. By exploiting these symbiotic relationships, we are able to engineer beneficial traits.

QV Bioelectronics

Seed Round in 2023
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.

Pickle Robot

Series A in 2022
Pickle Robots is a low cost, collaborative package handling robot that automates several key tasks along the e-commerce supply chain. Package handling is a physically demanding job with extremely high rates of turnover. The rising costs of shipping, comprised of 2/3rds labor, have become a major bottleneck to continued growth in e-commerce. Dill is the first robot from the Pickle Robot Company. It works multiple shifts, communicates with its human collaborators, and is rapidly developing new skills in handling e-commerce parcels: such as loading/unloading of feeder trucks, palletizing/depalletizing, and preloading of last mile delivery vans, trucks, and parcel cars.

Lumora

Venture Round in 2013
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on: - an integrated testing station for gastrointestinal (GI) infections, and - an HIV viral load monitoring system to support drug therapy in the developing world.

Ergomed

Venture Round in 2005
Ergomed plc is a profitable UK-based company, dedicated to the provision of specialized services to the pharmaceutical industry and the development of new drugs. It operates globally in over 40 countries. Ergomed plc has two complementary businesses: - The Services Business – a well-established, clinical research business providing services to the pharmaceutical and biotechnology industry; and - The Co-Development Business – a growing portfolio of partnerships with pharmaceutical and biotech companies, providing its drug development services in exchange for a carried interest in any revenues attributable to the drug asset, including outlicensing milestones as well as sales of the product.

CLYZ Labs

Private Placement in 2018
CLYZ Labs are developing a testing service to select the best drug therapy for personalised cancer treatment. CLYZ Labs will combine information on the sensitivity of the patients own tumor cells to a range of drugs along with biomarker and treatment guidelines to provide a personalised treatment recommendation. This is expected to increase life expectancy and reduce costs by selecting the best treatment option for an individual.

Whelan Refining

Venture Round in 2006
Whelan Refining Ltd recycles waste oil to produce base oil - the base for all industrial and automotive lubricants. It re-refines 50,000 tonnes per annum of used oils to produce a high-quality group I base oil for sale to the lubricant manufacturing industry. Whelan Refining was founded in 2005 and is based in Stoke-on-Trent, UK.

Xnor.ai

Private Placement in 2018
XNOR.AI, Inc. develops machine learning software models. It offers XNOR platform that allows product developers to run deep learning algorithms on a range of devices. Its applications are used in aerospace, automotive, retail, photography, consumer electronics, and government sectors. The company was founded in 2016 and is based in Seattle, Washington. As of January 15, 2020, XNOR.AI, Inc. operates as a subsidiary of Apple Inc.

Elucid mHealth

Private Placement in 2020
Elucid mHealth is a medication technology company creating adherence monitoring tools and virtual health platform aimed at improving clinical trial efficiencies. Elucid's novel product, Pill Connect, provides trial organizers with real-time adherence data and missed dose prevention, new dose data, protocol control, engagement measurements and automated dose reconciliation.

R5 Pharmaceuticals Ltd.

Seed Round in 2007
R5 Pharmaceuticals Ltd. engages in the contract development and manufacture of clinical trials materials.

5Degrees

Seed Round in 2011
5Degrees develops mobile and web-based CRM tools for startups and small businesses to grow sales. Its product portfolio includes 5Degrees CRM, an iPhone CRM App; Networker, a business card scanning app; and 5Degrees CRM Web. 5Degrees’s products enable users to import contacts from address books or Google contacts; put people into circles to easily manage overlapping networks; sync contacts with iPhones; use quick notes systems to jot notes; use templated emails and schedule them to be sent in the future; schedule to-do’s or tasks to keep in touch with contacts; receive alerts about the tasks for the day; view to-do lists; and call and email contacts. Its special features include LinkedIn integration, Box.com integration, offline facilities, multi-device synchronization, iPhone interfaces, and more. 5Degrees was founded in June 2011 and is based in Chicago, Illinois.

Manchester Imaging

Private Placement in 2018
Manchester Imaging Limited is a dental diagnostic software spinout from the University of Manchester. They have a computer vision and machine learning technology underpinning an image analysis software portfolio with development applications in several aspects of dental healthcare. These applications are being designed to identify dental decay and other potential problems earlier, empowering patients to look after their teeth more effectively and saving money for insurance companies and governments by reducing the need for dental restorations and repairs. Their diagnostic tools are based on pioneering image-recognition technology developed by the University’s researchers. This has proven itself in numerous applications throughout the world – facial and medical image recognition in particular – and now for the first time they are applying it to dental healthcare.
Renewable Technical Services Limited is a provider of installation, repair and maintenance services to the wind energy sector. The company supports major OEMs under preferred supplier / framework agreements, as well as working for the major power companies and wind-farm operators under long-term arrangements. With over 20 years of experience in installation and maintenance of met masts and wind turbines, the RTS team is available 24 hours a day, 7 days a week to support the wind energy industry. Having provided services to over 268 wind farms in the UK, it has worked on over 5,000 wind turbines. Our reach extends further still, with RTS engineers having worked on contracts in New Zealand, the Dominican Republic, Libya, South Africa and throughout Europe.

Michelson Diagnostics

Series A in 2014
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

De-Pack Ltd.

Venture Round in 2004
De-Pack Ltd. provides de-packaging, recycling, and recovery of aerosols.

Yourmedpack Limited

Private Placement in 2020
Yourmedpack Limited develops mobile medication manager application software for healthcare industry. Yourmedpack Limited was incorporated in 2016 and is based in Havant, United Kingdom.

Probe Scientific

Series A in 2009
Probe Scientific is developing innovative products to solve clinical problems and improve healthcare. The company has a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range to simultaneously benefit clinicians and the community in general. Probe Scientific Ltd is a private company, founded in 1998 and is based in the West Midlands, UK. Probe Scientific has grown steadily since its origins as a research organisation and has recently recruited experienced senior executives with a commercial focus.

Oxford BioTherapeutics

Venture Round in 2010
Oxford BioTherapeutics (OBT) is focused on the development of targeted medicines in the field of cancer. The company has signed strategic partnerships with the leading antibody companies Medarex, Biosite and Amgen to build a broad pipeline of novel antibody therapeutics using its unique OGAP® (Oxford Genome Anatomy Project) platform. OGAP® is one of the world’s largest proprietary human protein databases which contains and combines proteomic and genomic data with related clinical information. OBT also intends to develop companion diagnostics for selected antibody programmes. The company expects to improve disease management and treatment outcomes by integrating diagnostics into product development and commercialisation activities.

4energy

Venture Round in 2008
Located in Nottingham, 4energy produces cooling solutions that deliver up to 50% energy savings over traditional cooling products across the data centre and telecoms industries.

Michelson Diagnostics

Seed Round in 2007
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

Acea Health Limited

Private Placement in 2020
Acea Health Limited develops a digital dental and medical consent platform called Flynotes. The company caters to patients and clinicians. The company was incorporated in 2016 and is based in Guildford, United Kingdom.

CellAura

Venture Round in 2008
CellAura Technologies, Ltd. offers screening products for the drug discovery industry. It offers adenosine receptor agonist, adenosine receptor antagonist, beta-adrenergic receptor antagonist, dopamine receptor antagonist, histamine receptor antagonist, and muscarinic receptor antagonist. The company also offers a contract fluorescent ligand development and validation service through which a customer's specific product can be synthesized and a full pharmacological characterisation provided. CellAura Technologies, Ltd. is based in Nottingham, the United Kingdom.

CroBio

Private Placement in 2020
CroBio is a start-up founded by individuals specialising in microbiology and engineering. The company has a vision to create an environmentally sustainable solution to managing global agricultural drought. The companies current technology is based on a genetically engineered root-associated bacteria that has self-sustaining biologically active water retention. The bacteria naturally occur around the roots of many crops such as corn, wheat and soybean. By exploiting these symbiotic relationships, we are able to engineer beneficial traits.

Monica Healthcare

Venture Round in 2007
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Stage Coach

Acquisition in 2012
Stagecoach is a network of performing arts schools that teaches children and young people to sing, dance and act in a fun, educational, and stimulating environment

Monica Healthcare

Venture Round in 2009
Based in the United Kingdom, Monica Healthcare is developing a series of innovative wearable devices that will use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. The patented technology is based on the acquisition of electro-physiological signals that can be passively detected by electrodes positioned on the maternal abdomen.

Critical Pharmaceuticals

Venture Round in 2005
Critical Pharmaceuticals is a biotechnology company with proprietary drug delivery technologies for the sustained release and nasal delivery of proteins and peptides and labile or insoluble small molecules. Critical Pharmaceuticals was founded by Professor Steve Howdle in 2002 based on his research into supercritical fluids. When gases reach a certain temperature and pressure (the critical point) they become "supercritical" and take on both gas and liquid like properties. He noticed that supercritical carbon dioxide (scCO2) was able to penetrate certain polymers, and in a moment of inspiration realised that this could be used to mix thermally labile or solvent sensitive substances into the polymers.

Echo Ltd.

Venture Round in 2012
echo provides an extensive and bespoke range of IT and logistical support services through an outsourced partnership model. The service focused, flexible solutions enhance, expand and complement an existing service portfolio, improving cost efficiency while maintaining the highest quality service levels.

Systems Integration (Trading) Limited

Private Equity Round in 2009
Systems Integration (Trading) Limited supplies software and hardware solutions for the food processing industry. It offers Sistem 7 SHOP FLOOR DATA CAPTURE, which provides solutions for removing manual capture and transfer of information; Sistem 7 SALES ORDER PROCESSING, a system that offers an Explorer interface; and Sistem 7 BONING HALL, which is a program that allows quarters to be issued to the boning hall stock at the beginning of the boning process.

Crystallon

Venture Round in 2010
Crystallon Limited is the holding company for Oxford Cryosystems Limited which produces a world leading portfolio of low temperature devices in the field of x-ray crystallography.

Strella Biotechnology

Series A in 2022
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.

L3 Technology

Venture Round in 2008
L3 Technology develops a point of care testing system for reading blood analytes from various samples. It offers a lipid profile testing system for measuring a multi-fraction lipid profile from a finger stick sample of blood, serum, or plasma. The company was incorporated in 2001 and is based in Coventry, United Kingdom. As of December 16, 2016, L3 Technology was acquired by Jupiter Diagnostics.

Rinicare

Private Placement in 2018
Rinicare Ltd. designs and manufactures healthcare monitoring devices. The company manufactures devices called PRIME that provides vital sign monitoring and data analysis via wireless sensors and enables clinicians to remotely visualize, transmit, and store patient data. It also manufactures PRIME IoT that provides vital sign monitoring and transmits data to any connected, compatible device via its healthcare application software. It also develops falls detection and prevention system called SAFE that provides real-time monitoring and gives clinicians warning when a patient is at risk of falling. It uses a thermal imaging sensor and intelligent algorithms to detect the potential risk level of a patient’s position in a bed. The company also develops application software that tracks all patient data. Rinicare Ltd. was incorporated in 2002 and is based in Macclesfield, United Kingdom.

David Holmes BMW

Private Equity Round in 2006
Sytner Group Limited operates as a new and used car dealership company.

Accutronics

Venture Round in 2009
Accutronics Ltd designs, develops, and manufactures rechargeable batteries for portable and handheld electronic devices. The company offers accupro, custom designed battery packs and chargers for professional applications. It serves military, defense and security, medical and healthcare, industrial electronics, back-up systems, and portable electronic equipment markets. Accutronics Ltd engages in the distribution of range of Inspired Energy standard smart batteries, chargers and accessories The company was incorporated in 2009 and is based in Newcastle under Lyme, United Kingdom. As of January 13, 2016, Accutronics Ltd operates as a subsidiary of Ultralife Batteries (UK) Ltd.

Eden Luxury Group

Venture Round in 2008
Eden Luxury is a Chester-based travel brand that provides high end holidays through its Seasons in Style and Eden Collection.

Acea Health

Seed Round in 2018
Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .

KickSport

Venture Round in 2011
Kicksport.com is a martial arts equipment specialist, providing equipment and uniforms for Judo, Karate, and Taekwondo. KickSport's ethos is to provide quality clothing and exceptional customer service to all. KickSport's values include energy, dedication, leadership, evolution, aspiration, community, fashion, and quality.

Systems Integration

Venture Round in 2009
Systems Integration is one of the worlds leading suppliers of hardware and software solutions for the meat processing industry. With a wealth of knowledge drawn from their own experiences in the field, they have the ability to supply your organisation with state of the art technology coupled with bespoke software thus enabling your operation to run smoothly and efficiently.

Apex Molecular

Venture Round in 2016
Apex Molecular Ltd provides specialist chemistry services to pharmaceutical, biotechnology (life sciences), and applied chemistry sectors. The company offers laboratory-scale chemistry development services, including high potency synthesis, custom/contract synthesis, and development and scale-up. Its customers include drug discovery, biotechnology, and agritech companies. The company was formerly known as YProTech Ltd. and changed its name to Apex Molecular Ltd in 2019. Apex Molecular Ltd was incorporated in 2008 and is based in Alderley Edge, United Kingdom.

Critical Pharmaceuticals

Series B in 2007
Critical Pharmaceuticals is a biotechnology company with proprietary drug delivery technologies for the sustained release and nasal delivery of proteins and peptides and labile or insoluble small molecules. Critical Pharmaceuticals was founded by Professor Steve Howdle in 2002 based on his research into supercritical fluids. When gases reach a certain temperature and pressure (the critical point) they become "supercritical" and take on both gas and liquid like properties. He noticed that supercritical carbon dioxide (scCO2) was able to penetrate certain polymers, and in a moment of inspiration realised that this could be used to mix thermally labile or solvent sensitive substances into the polymers.

AMR Centre

Venture Round in 2017
Anti-Microbial Research Centre aims to accelerate the development of new antibiotics by providing development services to companies around the world in return for a commercial share from new products developed.

Comply

Venture Round in 2009
Comply provides specialized, off-the-shelf scientific and process data management software products, and offers Professional Consulting Services to support and enhance Life Science companies in successfully meeting unique industry demands.